WIPIT has advised healthtech company CollimateHealth on the legal aspects of its successful €6 million seed financing round. CollimateHealth is developing the first clinically scalable microbeam radiation therapy with the potential to fundamentally advance radiation treatment in oncology.

The new funding will enable the company to accelerate the development of its first clinical prototype and bring its technology one significant step closer to clinical application.

We are delighted to have supported the founding team of CollimateHealth in reaching this important milestone and would like to thank them for the trust they placed in us and for the constructive collaboration throughout the process. We also extend our thanks to all participating investors for their professionalism and collaborative approach.

The WIPIT team was led by Benedikt Mahr and also included Christian Deutscher (both Munich).

We congratulate CollimateHealth and all parties involved on the successful completion of the financing round and wish the company continued success in advancing this innovative technology.

‍